Clinical Trials Logo

Clinical Trial Summary

This study is designed to compare the length of continuous albuterol administration between two different albuterol formulations, BAC containing albuterol versus preservative free albuterol.


Clinical Trial Description

The primary objective of this study is to compare the length of continuous albuterol administration between patients receiving BAC containing albuterol versus preservative free albuterol. Secondary objectives include comparison of therapy escalation, asthma scores, forced expiratory volume in one second (FEV1) at discharge, length of hospital stay, and cost. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02966184
Study type Interventional
Source Norton Healthcare
Contact
Status Terminated
Phase Phase 4
Start date September 10, 2018
Completion date October 25, 2018

See also
  Status Clinical Trial Phase
Completed NCT02872597 - Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus Phase 1
Enrolling by invitation NCT00750568 - Intravenous Terbutaline in Severe Status Asthmaticus N/A
Completed NCT00124995 - Trial of Terbutaline for the Treatment of Status Asthmaticus in Children Phase 4
Recruiting NCT05819541 - Treating Exacerbations of Asthma With Oral Montelukast in Children Phase 2
Completed NCT01524198 - The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room Phase 2/Phase 3
Terminated NCT02780479 - Steroids in Children Hospitalized With Asthma Phase 4
Withdrawn NCT01403428 - Non Invasive Positive Pressure Ventilation in Status Asthmaticus Phase 2
Terminated NCT00683449 - Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma Phase 2
Withdrawn NCT03219736 - NiPPV in the Treatment of Acute Asthma Exacerbations N/A
Completed NCT00722020 - HFCWO in Hospitalized Asthmatic Children N/A
Withdrawn NCT03338205 - The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus Phase 3
Completed NCT02302261 - Pleth Variability and Asthma Severity in Children N/A
Recruiting NCT01770899 - Evaluation Montelukast in the Treatment of Status Asthmaticus N/A
Withdrawn NCT01188473 - Early Noninvasive Positive Pressure Ventilation in Children With Status Asthmaticus Phase 1
Withdrawn NCT04656587 - BPAP in Pediatric Asthma Pilot Study N/A
Completed NCT04929626 - Different Doses of Nebulized Magnesium Sulphate in Status Asthmaticus Phase 1
Completed NCT00623688 - Effectiveness and Cost Study Comparing Two Ways to Deliver Albuterol for the Treatment of Asthma in the Hospital N/A
Recruiting NCT00494572 - Montelukast With Status Asthmaticus, Ages 6-18 Phase 2/Phase 3
Recruiting NCT00491790 - Montelukast With Status Asthmaticus, Ages 2-5 Phase 2/Phase 3
Completed NCT00279786 - B2-Adrenergic Receptor Polymorphisms